Cargando…
Assessment of DHA on reducing early preterm birth: the ADORE randomized controlled trial protocol
BACKGROUND: Preterm birth contributes to 0.5 million deliveries in the United States (one of eight pregnancies) and poses a huge burden on public health with costs in the billions. Of particular concern is that the rate of earliest preterm birth (<34 weeks) (ePTB), which has decreased little sinc...
Autores principales: | Carlson, Susan E., Gajewski, Byron J., Valentine, Christina J., Rogers, Lynette K., Weiner, Carl P., DeFranco, Emily A., Buhimschi, Catalin S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5307851/ https://www.ncbi.nlm.nih.gov/pubmed/28193189 http://dx.doi.org/10.1186/s12884-017-1244-5 |
Ejemplares similares
-
Higher-Dose DHA Supplementation Modulates Immune Responses in Pregnancy and Is Associated with Decreased Preterm Birth
por: Valentine, Christina J., et al.
Publicado: (2021) -
Higher dose docosahexaenoic acid supplementation during pregnancy and early preterm birth: A randomised, double-blind, adaptive-design superiority trial
por: Carlson, Susan E, et al.
Publicado: (2021) -
Personalized medicine enrichment design for DHA supplementation clinical trial
por: Lei, Yang, et al.
Publicado: (2017) -
Evaluation of a Maternal Plasma RNA Panel Predicting Spontaneous Preterm Birth and Its Expansion to the Prediction of Preeclampsia
por: Weiner, Carl Philip, et al.
Publicado: (2022) -
DHA Supplementation Attenuates Inflammation-Associated Gene Expression in the Mammary Gland of Lactating Mothers Who Deliver Preterm
por: Adams, Joselyn M, et al.
Publicado: (2022)